Cargando…

Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data

OBJECTIVE: To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. SETTING/DESIGN: Secondary analysis of international published data. DATA SOURCES: Meta-analysis of COVID-19 incubation period and a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Casey-Bryars, Miriam, Griffin, John, McAloon, Conor, Byrne, Andrew, Madden, Jamie, Mc Evoy, David, Collins, Áine, Hunt, Kevin, Barber, Ann, Butler, Francis, Lane, Elizabeth Ann, O'Brien, Kirsty, Wall, Patrick, Walsh, Kieran, More, Simon John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245290/
https://www.ncbi.nlm.nih.gov/pubmed/34183334
http://dx.doi.org/10.1136/bmjopen-2020-041240
_version_ 1783716086785507328
author Casey-Bryars, Miriam
Griffin, John
McAloon, Conor
Byrne, Andrew
Madden, Jamie
Mc Evoy, David
Collins, Áine
Hunt, Kevin
Barber, Ann
Butler, Francis
Lane, Elizabeth Ann
O'Brien, Kirsty
Wall, Patrick
Walsh, Kieran
More, Simon John
author_facet Casey-Bryars, Miriam
Griffin, John
McAloon, Conor
Byrne, Andrew
Madden, Jamie
Mc Evoy, David
Collins, Áine
Hunt, Kevin
Barber, Ann
Butler, Francis
Lane, Elizabeth Ann
O'Brien, Kirsty
Wall, Patrick
Walsh, Kieran
More, Simon John
author_sort Casey-Bryars, Miriam
collection PubMed
description OBJECTIVE: To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. SETTING/DESIGN: Secondary analysis of international published data. DATA SOURCES: Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. PARTICIPANTS: Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. METHODS: Simulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset, and the proportion of presymptomatic transmission, were estimated. OUTCOME MEASURES: Transmission time of SARS-CoV-2 relative to symptom onset and proportion of presymptomatic transmission. RESULTS: Based on 18 serial interval/generation time estimates from 15 papers, mean transmission time relative to symptom onset ranged from −2.6 (95% CI −3.0 to –2.1) days before infector symptom onset to 1.4 (95% CI 1.0 to 1.8) days after symptom onset. The proportion of presymptomatic transmission ranged from 45.9% (95% CI 42.9% to 49.0%) to 69.1% (95% CI 66.2% to 71.9%). CONCLUSIONS: There is substantial potential for presymptomatic transmission of SARS-CoV-2 across a range of different contexts. This highlights the need for rapid case detection, contact tracing and quarantine. The transmission patterns that we report reflect the combination of biological infectiousness and transmission opportunities which vary according to context.
format Online
Article
Text
id pubmed-8245290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82452902021-07-01 Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data Casey-Bryars, Miriam Griffin, John McAloon, Conor Byrne, Andrew Madden, Jamie Mc Evoy, David Collins, Áine Hunt, Kevin Barber, Ann Butler, Francis Lane, Elizabeth Ann O'Brien, Kirsty Wall, Patrick Walsh, Kieran More, Simon John BMJ Open Epidemiology OBJECTIVE: To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. SETTING/DESIGN: Secondary analysis of international published data. DATA SOURCES: Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. PARTICIPANTS: Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. METHODS: Simulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset, and the proportion of presymptomatic transmission, were estimated. OUTCOME MEASURES: Transmission time of SARS-CoV-2 relative to symptom onset and proportion of presymptomatic transmission. RESULTS: Based on 18 serial interval/generation time estimates from 15 papers, mean transmission time relative to symptom onset ranged from −2.6 (95% CI −3.0 to –2.1) days before infector symptom onset to 1.4 (95% CI 1.0 to 1.8) days after symptom onset. The proportion of presymptomatic transmission ranged from 45.9% (95% CI 42.9% to 49.0%) to 69.1% (95% CI 66.2% to 71.9%). CONCLUSIONS: There is substantial potential for presymptomatic transmission of SARS-CoV-2 across a range of different contexts. This highlights the need for rapid case detection, contact tracing and quarantine. The transmission patterns that we report reflect the combination of biological infectiousness and transmission opportunities which vary according to context. BMJ Publishing Group 2021-06-28 /pmc/articles/PMC8245290/ /pubmed/34183334 http://dx.doi.org/10.1136/bmjopen-2020-041240 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Casey-Bryars, Miriam
Griffin, John
McAloon, Conor
Byrne, Andrew
Madden, Jamie
Mc Evoy, David
Collins, Áine
Hunt, Kevin
Barber, Ann
Butler, Francis
Lane, Elizabeth Ann
O'Brien, Kirsty
Wall, Patrick
Walsh, Kieran
More, Simon John
Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
title Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
title_full Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
title_fullStr Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
title_full_unstemmed Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
title_short Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
title_sort presymptomatic transmission of sars-cov-2 infection: a secondary analysis using published data
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245290/
https://www.ncbi.nlm.nih.gov/pubmed/34183334
http://dx.doi.org/10.1136/bmjopen-2020-041240
work_keys_str_mv AT caseybryarsmiriam presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT griffinjohn presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT mcaloonconor presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT byrneandrew presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT maddenjamie presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT mcevoydavid presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT collinsaine presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT huntkevin presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT barberann presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT butlerfrancis presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT laneelizabethann presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT obrienkirsty presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT wallpatrick presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT walshkieran presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata
AT moresimonjohn presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata